The field of epilepsy research has rapidly evolved with an appreciation that seizures arise from dysfunctions in distributed ...

Dyslexia is a common developmental disorder, affecting around 7% of the global population. It is characterized by ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

The US FDA has approved the FL-100, the first at-home brain-stimulation device for treating moderate to severe major depressive disorder, following successful trials.

Anxiety is often described as a whole‑brain problem, but a series of mouse experiments suggests that, in some cases, a single ...

A clinic in Bellevue talks about transcranial magnetic stimulation. The new technology is becoming more widely available to ...

I spoke with neuroscientists from an Incheon, Korea-based startup that's looking to minimize the symptoms of epilepsy or Parkinson's disease.

Neurostimulation devices market was valued at US$ 9.84 billion in 2024 and is projected to hit the market valuation of US$ 22.64 billion by 2033 at a CAGR of 9.7% during the forecast period 2025–2033.

August 8, 2025 • When bestselling author Kelly Corrigan's creativity runs low or her mood turns, she doesn't power through. Here are her tips for connecting your body to your creative process and ...